(c) 2002 JIP
Readers in March 2002:
Readers in the past year:
Asked Questions about the Journal of Informed Pharmacotherapy
What is the JIP?
- The JIP is a peer-reviewed online journal dedicated to the practice of rational
pharmacotherapy through the use of evidence-based principles.
- The JIP fosters the rapid widespread dissemination of original research findings, as
well as information intended to help pharmacotherapy practitioners (i.e. pharmacists,
physicians, nurses and other health care providers) provide better care for their
Why was the JIP created?
- The idea for the Journal arose out of a recognized need for the following:
- A new peer-reviewed journal that focuses on pharmacotherapy
- A journal that provides pharmacotherapy literature reviews which
highlight, condense, interpret and put this information into proper perspective using
- An alternative to traditional hardcopy distribution to facilitate the
rapid and worldwide dissemination of original research activity reports.
- A journal that is accessible to all, for a price that all can afford
What is the history of the JIP?
- The idea for the JIP was originated in late 1998 by the Founding Editors (top left of
this page). Since then, the Founding Editors have been busy
forming an editorial board and the processes by which the JIP will fulfill its mission.
Who is expected to read the JIP?
- The JIP is intended for any health care professional with an interest in optimizing
What makes the JIP unique?
- JIP is the only peer-reviewed online journal devoted entirely to pharmacotherapy
- JIP provides a strong evidence-based perspective through peer-reviewed
research and reviews of the pharmacotherapy literature which put the research findings
into their proper context
- JIP provides a venue for clinicians to widely disseminate research findings
(the second it is placed on the Web, it is accessible from any internet
terminal on the planet).
- JIP provides more rapid dissemination of information than traditional
print journals (for example, we expect turnaround time for articles to
be a few weeks, vs. a few months for old-style journals)
- JIP does not require a paid subscription to access
Is the JIP linked to the Pharmaceutical Industry?
- No. There is no financial relationship between the JIP and any pharmaceutical
- As with other respected peer-reviewed journals, relationships between authors and such
companies must be declared in writing at the time of submission and the details will be
provided to the readership in conjunction with any resulting publications.
How is the JIP organized?
- The day-to-day operations of the JIP are run by the Founding Editors on a voluntary
- Section Editors have been selected based upon their recognized clinical and research
expertise in a specific area of pharmacotherapeutics (e.g.. cardiology, infectious diseases,
- Section Editors are drawn mainly from the United States and Canada.
- Expert reviewers have been drawn from the global pool of
pharmacotherapeutics practitioners and researchers.
What are the responsibilities of JIP Section Editors?
- As a Section Editor, commitment to the following is required:
- A new peer-reviewed journal that focuses on pharmacotherapy
- Coordinate the assessment of submissions related to your area of
specialty. This involves approximately 2-3 submissions per year.
- Identify and facilitate the involvement of 2-3 reviewers for each
submission sent to you.
- Provide your own recommendation as to the suitability of each submission
- By invitation or voluntarily provide other input related to your
specialty area such as evidence-based reviews of the pharmacotherapeutic literature,
reviews of websites or editorials.
- Provide a review turnaround time of 4 weeks or less to ensure a prompt
(but thorough) review of each submission.
- Be conversant in the use of email (including the ability to send and
receive file attachments) and the internet and have ready access to both. All submissions
to the Journal must be in Microsoft Word 97/2000 format, so editors/reviewers must have
access to and skills in using this word processing software.
- Be willing to make a one year commitment to participation as a Section
- Although these responsibilities may sound onerous, there are several Section Editors and
most of the administrative duties are handled by the Managing/Founding Editors.
Accordingly, the workload for Section Editors should be manageable.
- Regardless of whether you are called upon to provide input to the Journal, you would be
listed as a Section Editor in all issues of the Journal on the website.
- More details
about reviewer responsibilities.
What is the format of the JIP?
What types of information does the JIP contain?
- PEER REVIEWED ORIGINAL RESEARCH ARTICLES
- EVIDENCE-BASED REVIEWS OF THE
Evidence-based reviews of the pharmacotherapeutic literature with
emphasis on interpretation of the findings, designed to help practitioners put the
findings into proper perspective. Written by experts in the field.
- ISSUES IN PHARMACOTHERAPY PRACTICE
Articles from a variety of sources focusing on therapeutic reviews,
practice-related issues, an controversies. These articles undergo
editorial review prior to publishing.
- RESEARCH ABSTRACTS
An opportunity for researchers to rapidly disseminate their
findings in abstract form.
- PHARMACOTHERAPY ON THE WEB
Reviews of pharmacotherapy-related websites and other online
clinical information resources. Designed to aid practitioners in
finding high-quality information as well as using for the internet to
enhance their practice.
- E-MAIL TO THE EDITOR
Allows rapid interpretation, criticism, and discussion of articles in
the Journal (or otherwise) by readers.
What about Permanence?
- One of the primary problems with electronic publication is the difficulty
guaranteeing permanence. For many, the fear that a journal may disappear after a short
period of publication is enough to deter subscription or submission to that journal. This
is particularly a problem for independent journals which often do not have the technical
infrastructure or expertise to guarantee permanence.
- The JIP will address this issue by using the Journal Backup service
provided by the International Consortium for Alternative
Academic Publishing (ICAAP) which provides a backup service which ensures the latest
version of this publication will always be available at a central location. In addition to
ensuring quick access, this also provides the service of ensuring continuity of access
even if we discontinue publication.
- The site will also be "mirrored" through the ICAAP mirroring service. With this service, I.C.A.A.P.
provides fast North American mirrors for international users. Mirrors are essentially
duplicate copies of the original publications housed on alternate servers. Users choose
the server closest to their geographic location thereby increasing speed of access and
Why should authors consider submitting articles for publication
in the JIP?
If accepted, authors can expect to have their articles available to a
worldwide audience within a few weeks of submission
Authors will have their articles reviewed by established experts in
Authors can expect to be amongst the first to have articles published in
a online peer-reviewed journal
Authors will support the principles of alternative academic publishing, thereby
slowing the decay in our university library systems caused by exorbitant subscription fees
charged by publication houses for traditional print journals.
How does the JIP peer-review process work?
- Articles submitted for peer review will undergo a rigorous traditional peer review
process intended to minimize the likelihood of release of scientifically unfounded or
biased results while minimizing the time it takes to make valid results available.
- Generally, the process looks something like this:
1. Founding editors review submission for worthiness of external peer-review.
2. If deemed worthy of peer-review, blinded review by at least two experts in the
therapeutic area concerned is conducted.
3. Feedback from reviewers is received by Founding Editors and
publication-worthiness is assessed.
4. If deemed potentially worthy of publication, comments and suggestions from
reviewers are collated and conveyed to the author.
5. If the author wishes to address the comments / concerns raised by the JIP
reviewers, he/she edits the document as appropriate and sends it back to the founding
6. If the reviewer's concerns have been substantially addressed, the article
undergoes final editing and is released for publication. If there is still concern
that the reviewers comments have not been properly addressed, the article may be sent back
to the reviewers for their input.
- See the JIP's detailed peer-review
algorithm in PDF format.
How are JIP citations referenced and cited?
- Since issues of the JIP are dynamic in the sense that they are built up over time as the
articles are completed, we have devised a system that should still make it easy to
identify and cite JIP articles
- Articles published during each calendar quarter (i.e. 3-month period) will be identified
by year, issue (1-4) and page numbers according to the Vancouver
- Page numbers will be assigned sequentially from the first article in the issue through
to the closing date for that issue
- Thus, JIP articles may be cited in the standard Vancouver Group
format (e.g. J Inform Pharmacother 2000;3:45-52) or by using standard web
citation formats, such as:
Marra C. Public Access Comput Syst Rev [serial on-line] 2000;3(4):109-15. Available
from: Public Access Computer Systems Forum PACS-L via the Internet
(http://www.pubaccess.com). Accessed 29 Nov 1999.
How often is the JIP issued?
- Unlike traditional print journals, articles in the JIP will be issued on a continuous
basis. As soon as an article has completed the appropriate review process, it will
be posted to the JIP website.
- Delays related to episodic publishing (e.g. monthly editions) are avoided.
How much does it cost to subscribe to the JIP?
- Nothing. The JIP will be accessible at no cost over the internet.
- Users will only be required to have the necessary hardware/software for access
- A free password-based "subscriber" access system may be set up in the future
to allow us to track the nature of our readership, however, no information about our
readers will be released to any other agency.
Please direct any inquiries or comments about the
Journal to the Publishing Editors. If you have any
recommendations for journal content, we would be pleased to receive your ideas.
Last updated: April 19, 2002